Press Releases
Press Release
Cardiol Therapeutics Announces First Patient Enrolled in ARCHER, a Phase II Clinical Trial of CardiolRx™ for Treatment of Acute Myocarditis
August 03, 2022
Press Release
Cardiol Therapeutics Reports Results of 2022 Annual General Meeting
June 29, 2022
Press Release
Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 p.m. EDT
June 27, 2022
Press Release
Cardiol Therapeutics Announces At-The-Market Equity Offering Program
June 09, 2022
Press Release
Cardiol Therapeutics Appoints Teri Loxam and Chris Waddick to its Board of Directors
May 19, 2022
Press Release
Cardiol Therapeutics Announces FDA Investigational New Drug Application (IND) Authorization for Multicenter Phase II Open-label Pilot Study of CardiolRx™ for Recurrent Pericarditis
May 17, 2022
Press Release
Cardiol Therapeutics Announces Year-End 2021 Update on Operations
March 24, 2022
Press Release
Cardiol Therapeutics to Participate in Cantor Fitzgerald’s Virtual Rare Orphan Disease Summit
March 22, 2022
Press Release
Cardiol Therapeutics Appoints Jennifer M. Chao to its Board of Directors
March 15, 2022